Benjamin L Palleiko

CHIEF EXECUTIVE OFFICER

Benjamin L Palleiko (CHIEF EXECUTIVE OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in KALV. The largest single filing was $293K of KALV (10,926 sh × $26.78, as filed), executed May 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.0M

shares × price, as filed

Last traded

May 22

Filed May 26

Open performance→

Volume by month

Buys $0 Sells $2.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 6 filings

Sector per market data · by filing · past 12 months

Most traded names

KALV KALV KALV · 0 buys · 12 sells 12 filings

Recent filings

KALVSALE KalVista Pharmaceuticals, Inc. View filing → $293K
10,926 sh × $26.78
Exec May 22
Filed May 26 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $193K
9,550 sh × $20.22
Exec Apr 17
Filed Apr 20 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $108K
6,693 sh × $16.08
Exec Mar 9
Filed Mar 10 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $156K
10,034 sh × $15.57
Exec Feb 23
Filed Feb 24 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $120K
7,294 sh × $16.51
Exec Dec 8 2025
Filed Dec 9 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $147K
10,940 sh × $13.45
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $116K
7,294 sh × $15.84
Exec Sep 8 2025
Filed Sep 9 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $145K
10,940 sh × $13.22
Exec Aug 22 2025
Filed Aug 25 2025 · 5:30 PM ET More filings →